| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/30/2002 | WO2002012328A8 Compositions and methods for the therapy and diagnosis of colon cancer |
| 05/30/2002 | WO2002012277A3 Hybrid combinatorial proteins made from reshuffling of differently folded domains |
| 05/30/2002 | WO2002011785A3 Manipulation of arterial-venous identity |
| 05/30/2002 | WO2002010346A3 Insulin producing cell-line obtained by electrofusion |
| 05/30/2002 | WO2002008426A3 Fh-binding protein of streptococcus pneumoniae |
| 05/30/2002 | WO2002008412A3 Use of cyp52a2a promoter to increase gene expression in yeast |
| 05/30/2002 | WO2002006477A9 A novel polypeptide-homo topoisomerase 12.1 and polynucleotide encoding said polypeptide |
| 05/30/2002 | WO2002006319A3 Nucleic acid molecule which codes for a plant amp deaminase |
| 05/30/2002 | WO2002002807A8 Diagnosis of diseases associated with cell signalling |
| 05/30/2002 | WO2002002738A3 Host cells containing multiple integrating vectors |
| 05/30/2002 | WO2002000895A3 Bordetella bronchiseptica mutant which produces recombinant pertussis toxin and uses thereof |
| 05/30/2002 | WO2001098534A3 Matrix screening method |
| 05/30/2002 | WO2001098482A3 Liver-specific gene expression cassettes, and methods of use |
| 05/30/2002 | WO2001096577A8 Production of secreted polypeptides |
| 05/30/2002 | WO2001096396A3 Heliothis glutamate receptor |
| 05/30/2002 | WO2001095724A3 Methods of improving the effectiveness of transgenic plants |
| 05/30/2002 | WO2001094598A3 Nucleic acid construct useful for expressing transgenes in particular in embryonic stem cells |
| 05/30/2002 | WO2001094562A3 Cold sensitive mutant dna polymerases |
| 05/30/2002 | WO2001094561A3 The non-mevalonate isoprenoid pathway |
| 05/30/2002 | WO2001094380A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 05/30/2002 | WO2001092580A3 Lyophilizable and enhanced compacted nucleic acids |
| 05/30/2002 | WO2001092565A8 Diagnosis of diseases associated dna transcription by means of assessing the methylation status of genes associated with dna transcription |
| 05/30/2002 | WO2001092296A3 Regulation of human isotocin-like g protein-coupled receptor |
| 05/30/2002 | WO2001090385A3 IRON REGULATION OF THE PpSEC10 TRANSCRIPTIONAL REGULATORY REGION OF PICHIA PASTORIS AND METHODS OF USE |
| 05/30/2002 | WO2001088139A3 Proteins interacting with a sucrose transporter |
| 05/30/2002 | WO2001087979A3 Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci |
| 05/30/2002 | WO2001087934A3 Treatment of neoplasia/transformation using a pituitary tumor transforming gene carboxy terminal peptides |
| 05/30/2002 | WO2001087929A3 Regulation of human dopamine-like g protein-coupled receptor |
| 05/30/2002 | WO2001087330A3 Compositions and methods for achieving immune suppression |
| 05/30/2002 | WO2001081413A3 Isolated human transporter proteins, nucleic acids and uses thereof |
| 05/30/2002 | WO2001079517A3 Control of fruit dehiscence in arabidopsis by indehiscent1 genes |
| 05/30/2002 | WO2001079512A3 Vector and method for targeted replacement and disruption of an integrated dna sequence |
| 05/30/2002 | WO2001079498A3 16051a and 16051b, novel human pdz family members and uses thereof |
| 05/30/2002 | WO2001075121A9 16836, a human phospholipase c family member and uses thereof |
| 05/30/2002 | WO2001075119A3 21509 and 33770, novel human dehydrogenase family members and uses thereof |
| 05/30/2002 | WO2001073094A3 Novel sperm-dna complexes for genetically modifying non-human animals |
| 05/30/2002 | WO2001073030A3 Compositions and methods of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 05/30/2002 | WO2001071014A3 Expression of recombinant human acetylcholinesterase in transgenic plants |
| 05/30/2002 | WO2001068888A3 Production of chimeric capsid vectors |
| 05/30/2002 | WO2001068857A3 18615 and 48003, human ion channels and uses therefor |
| 05/30/2002 | WO2001068814A3 Multipotent cell and cardiomyocyte cell populations, and routes to and uses of same |
| 05/30/2002 | WO2001068704A3 G-protein coupled receptors |
| 05/30/2002 | WO2001066776A3 Novel l-form bacterial strains, method for producing same and the use thereof for producing gene products |
| 05/30/2002 | WO2001066760A3 Novel human kinase interacting protein and polynucleotides encoding the same |
| 05/30/2002 | WO2001066746A3 G-protein coupled receptor related polypeptides |
| 05/30/2002 | WO2001064877A3 Human schizophrenia gene |
| 05/30/2002 | WO2001055434A8 Inhibition of carbohydrate-modifying enzymes in host organisms |
| 05/30/2002 | WO2001053473A3 Methods for amplifying genetic material and uses thereof |
| 05/30/2002 | WO2001049847A3 26904, 38911, and 39404, seven-transmembrane proteins/g-protein coupled receptors |
| 05/30/2002 | WO2001049840A3 Spf1-related transcription factors |
| 05/30/2002 | WO2001048187A3 A molecular switch for regulating mammalian gene expression |
| 05/30/2002 | WO2001047638A3 Integrated microfluidic disc |
| 05/30/2002 | WO2001046467A3 Fluorescent intensity assay for duplex and triplex nucleic acid hybridization in solution utilizing fluorescent intercalators |
| 05/30/2002 | WO2001046243A3 A new polypeptide-ring finger protein 8 and the polynucleotide encoding it |
| 05/30/2002 | WO2001045494A9 Pyrophosphatase stress-related proteins and methods of use in plants |
| 05/30/2002 | WO2001044816A3 Conformational and topological protein regulation |
| 05/30/2002 | WO2001043876A9 Devices and methods for making bioarrays |
| 05/30/2002 | WO2001042509A9 Use of multiple recombination sites with unique specificity in recombinational cloning |
| 05/30/2002 | WO2001042508A9 Methods and compositions relating to electrical detection of nucleic acid reactions |
| 05/30/2002 | WO2001042473A3 Device and method for accelerated hydration of dry chemical sensors |
| 05/30/2002 | WO2001042455A9 Directed evolution of biosynthetic and biodegration pathways |
| 05/30/2002 | WO2001041931A9 Multilayered microfluidic devices for analyte reactions |
| 05/30/2002 | WO2001040306A9 Human antibodies as detection reagents |
| 05/30/2002 | WO2001038511A8 Resolvase-catalysed, sequence-specific dna-recombination in eukaryotic cells |
| 05/30/2002 | WO2001037194A9 Crystallizable compositions comprising a caspase-7 |
| 05/30/2002 | WO2001034821A3 Chemical inducible promoter used to obtain transgenic plants with a silent marker and organisms and cells and methods of using same for screening for mutations |
| 05/30/2002 | WO2001031058A3 Identification of cells for transplantation |
| 05/30/2002 | WO2001030998A9 Production of functional hybrid genes and proteins |
| 05/30/2002 | WO2001029063A8 Death domain-containing receptor polynucleotides, polypeptides, and antibodies |
| 05/30/2002 | WO2001021795A9 Fatty acid transport proteins |
| 05/30/2002 | WO2001016300A3 Method of identifying inhibitors of cdc25 |
| 05/30/2002 | WO2001004360A3 Retroviral recombination assays and uses thereof |
| 05/30/2002 | WO2000078952A8 Human rna metabolism proteins (rmep) |
| 05/30/2002 | WO2000075366A3 Transcription-based gene mapping |
| 05/30/2002 | WO2000052205A8 cDNA FOR HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE |
| 05/30/2002 | US20020066124 GTP binding stress-related proteins and methods of use in plants |
| 05/30/2002 | US20020066123 Transgenic plants; disease resistance |
| 05/30/2002 | US20020066122 Hypersensitive response elicitor from Xanthomonas campestris |
| 05/30/2002 | US20020066121 Whisker-mediated transformation of embryogenic cotton suspension cultures |
| 05/30/2002 | US20020066120 Plant myb-related transcription factors |
| 05/30/2002 | US20020066119 Regulatory sequences for use in generation of disease and damage resistant plants |
| 05/30/2002 | US20020066117 Transgenic animal and methods |
| 05/30/2002 | US20020066116 Endometriosis mouse model |
| 05/30/2002 | US20020065408 Generating heterologous proteins in eukaryotic cells; obtain cell, transform, express vector, recover heterologous protein |
| 05/30/2002 | US20020065407 Nucleotide sequences coding preferential polypeptide for use in the immunization of animal against viral diseases |
| 05/30/2002 | US20020065406 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of hematopoietic defects |
| 05/30/2002 | US20020065403 New nucleotide sequences which code for pck gene |
| 05/30/2002 | US20020065398 Humanized and chimeric monoclonal antibodies that recognize epidermal growth factor receptor (egf-r); diagnostic and therapeutic use |
| 05/30/2002 | US20020065396 Compositions and methods of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 05/30/2002 | US20020065395 Polypeptide for use as diagnostic tool in screening bactericides |
| 05/30/2002 | US20020065393 Human hypoxanthine- (guanine) phosphoribosy1 transferase-2 |
| 05/30/2002 | US20020065392 Methods for production of protein |
| 05/30/2002 | US20020065292 Pyrazole compounds, pharmaceutical compositions, and methods for modulating or inhibiting ERAB or HADH2 activity |
| 05/30/2002 | US20020065243 Controlled activation of DNA molecules for gene therapy using a heat- or light-inducible promoter; levels of gene expression modulated by antibiotic concentrations; side- effects reduction; breast/ovarian/prostate cancers; tumors |
| 05/30/2002 | US20020065241 A recombinant polynucleotide of first polynucleotides coding an antigenic peptide and are operatively linked to each other to enhance translation of the polynucleotides to the peptides and binding to MHC; cancer vaccine |
| 05/30/2002 | US20020065239 Antidiabetic agents; obesity and diabetic-related conditions; administration of vectors encoding the following: glucokinase regulatory protein alone or co-administered with glucokinase or with metabolism modififying proteins |
| 05/30/2002 | US20020065238 EPO primary response gene, EPRG3pt |
| 05/30/2002 | US20020065237 SBHWSB1 polypeptides/polynucleotides produced by recombinant techniques; gene therapy; diagnostic tests; agonists; antagonists; "positional cloning"; sequence of Serine(S), Aspargine/Asparic Acid(W), Histidine (H) and Tryptophan (T) |
| 05/30/2002 | US20020065236 Reducing the inflammatory response to gene therapy by modifying a plasmid or viral vector to reduce or eliminate the immunostimulatory response by removing a CpG (cytosine-guanosine dinucleotide) motif or methylating a CpG motif |
| 05/30/2002 | US20020065223 Isolated nucleic acid molecules encoding C/SKARP)-1 (Cardiac/Skeletal Muscle-Restricted Ankyrin-Repeat Containing Protein); antisense nucleic acid molecules, recombinant expression vectors; cardiotonic agents; muscles disorders |